Home

News

 

What is a health outcome? View and listen to the ICHOM video.
HARMONY Networking at ASH2017, the 59th Annual Meeting and Exposition of American Society of Hematology
Connecting at the 1st European Alliance for Personalised Medicine Congress 2017
Making Change Happen in Health: Harnessing the Benefits of Science and more
Summarizing the HARMONY Workshop on the Definition of Meaningful Outcomes for HMs
HARMONY at the 59th Annual Meeting of the American Society of Hematology in Atlanta, USA.
HARMONY Work Packages 2 & 6 Leadership in action in London, during Workshop: Meaningful Outcomes for HMs
Part 1: Offering in-depth Interviews to learn more about the HARMONY Alliance Goals and Objectives
Part 2: Offering in-depth Interviews to learn more about the HARMONY Alliance Goals and Objectives - Pt. 2
Progress in Using Big Data Technology to Achieve Better Outcomes for Patients with Blood Cancers: First year achievements
Data Sharing from Clinical Trials: A Research Funder’s Perspective: new NEJM article
IPSOR: Including the Patient Perspective in Health Care Decision Making
New IMI brochure ‘Carry the torch’ highlighting impacts of IMI projects
About the US initiative: Cancer Moonshot
HARMONY Interactive session at the 1st European Alliance for Personalised Medicine Congress.
Press Release | Progress in Using Big Data Technology to Achieve Better Outcomes for Patients with Blood Cancers
HARMONY Workshop on the definition of Outcomes
Valuable Interactions at the 2nd HARMONY General Assembly on 23 and 24 October in Berlin, Germany
Is the pharma industry missing the big picture? And can data-driven approaches reveal it? Sharing the new Elsevier Reaxys white paper.
Press Release HARMONY Alliance: Challenges and Opportunities for Using Big Data to Treat Hematologic Malignancies (HMs).
HARMONY Represented at the IMI Stakeholder Forum 2017
Meanwhile in the USA: a $215-million infusion to support immunotherapy work
Working together with patient groups. Sharing the EFPIA Patient Think Tank publication.
Data, data everywhere: the challenges of personalised medicine, new BJM article
1-24   25-48   49-72   73-96   97-120   121-144   145-168   169-192